+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Identification of key genes related to high-risk gastrointestinal stromal tumors using bioinformatics analysis



Identification of key genes related to high-risk gastrointestinal stromal tumors using bioinformatics analysis



Journal of Cancer Research and Therapeutics 14(Suppl.): S243-S247



The purpose of this study was to identify predictive biomarkers used for clinical therapy and prognostic evaluation of high-risk gastrointestinal stromal tumors (GISTs). In this study, microarray data GSE31802 were used to identify differentially expressed genes (DEGs) between high-risk GISTs and low-risk GISTs. Then, enrichment analysis of DEGs was conducted based on the gene ontology and kyoto encyclopedia of genes and genomes pathway database. In addition, the transcription factors and cancer-related genes in DEGs were screened according to the TRANSFAC, TSGene, and TAG database. Finally, protein-protein interaction (PPI) network was constructed and analyzed to look for critical genes involved in high-risk GISTs. A total of forty DEGs were obtained and these genes were mainly involved in four pathways, including melanogenesis, neuroactive ligand-receptor interaction, malaria, and hematopoietic cell lineage. The enriched biological processes were related to the regulation of insulin secretion, integrin activation, and neuropeptide signaling pathway. Transcription factor analysis of DEGs indicated that POU domain, class 2, associating factor 1 (POU2AF1) was significantly downregulated in high-risk GISTs. By constructing the PPI network of DEGs, ten genes with high degrees formed local networks, such as PNOC, P2RY14, and SELP. Four genes as POU2AF1, PNOC, P2RY14, and SELP might be used as biomarkers for prognosis of high-risk GISTs.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 065212956

Download citation: RISBibTeXText

PMID: 29578181


Related references

Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis. Molecular Medicine Reports 18(5): 4499-4515, 2018

Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk marker. Annals of Surgical Oncology 19(11): 3491-3499, 2013

Clinical characteristics and prognostic analysis of 45 patients with high-risk gastrointestinal stromal tumors. Zhonghua Wei Chang Wai Ke Za Zhi 16(3): 251-255, 2014

Identification of key genes in glioblastoma-associated stromal cells using bioinformatics analysis. Oncology Letters 11(6): 3999-4007, 2016

Thymosin beta-4 overexpression correlates with high-risk groups in gastric gastrointestinal stromal tumors: A retrospective analysis by immunohistochemistry. Pathology, Research and Practice 213(9): 1139-1143, 2017

Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors. Annals of Diagnostic Pathology 11(1): 27-33, 2007

9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations. Cancer 104(1): 159-169, 2005

Mutational analysis of CASP1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 14 genes in gastrointestinal stromal tumors. Human Pathology 40(6): 868-871, 2009

Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors. Human Pathology 33(3): 316-321, 2002

Comprehensive analysis of genes involved in the malignancy of gastrointestinal stromal tumors. Anticancer Research 30(7): 2705-2715, 2010

Multidetector CT of high-risk patients with occult gastrointestinal stromal tumors. Ajr. American Journal of Roentgenology 180(1): 185-189, 2002

Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy. Annals of Surgery 247(6): 1011-1018, 2008

Analyzing the molecular mechanism of the tissue specificity of gastrointestinal stromal tumors by using bioinformatics approaches. Journal of BUON 23(4): 1149-1155, 2018

Identification of macrophage-related candidate genes in lupus nephritis using bioinformatics analysis. Cellular Signalling 46: 43-51, 2018

Follow up of three cases after adjuvant treatment of high risk gastrointestinal stromal tumors with Imatinib. Annals of Oncology 18(6): 1123-1125, 2007